950160 — Kolon TissueGene Share News
0.000.00%
Last trade - 00:00- KR₩7tn
- KR₩7tn
- $3.63m
Brief: Kolon Tissuegene Highlights Long-Term Safety Data And Potential U.S. FDA Pathway For Tg-C At Oarsi World Congress
Brief: Kolon Tissuegene To Conduct Capital Increase Of 44 Billion Won For Operational Funds
Brief: Kolon Tissuegene To Conduct Capital Increase Of 48 Billion Won For Operational Funds
Brief: Kolon Corp 2017/2018 Financial Statements Are Subject To Change Depending On Audit Results
Brief: TissueGene to change company name to Kolon TissueGene
Brief: TissueGene proposes to change company name to Kolon TissueGene